These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16447299)

  • 21. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Criteria to hepatitis C treatment response].
    Levi D; Tanno H; Descalzi V
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S50-2; discussion S74-82. PubMed ID: 16862861
    [No Abstract]   [Full Text] [Related]  

  • 23. Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection.
    ; McCaughan GW; Omata M; Amarapurkar D; Bowden S; Chow WC; Chutaputti A; Dore G; Gane E; Guan R; Hamid SS; Hardikar W; Hui CK; Jafri W; Jia JD; Lai MY; Wei L; Leung N; Piratvisuth T; Sarin S; Sollano J; Tateishi R
    J Gastroenterol Hepatol; 2007 May; 22(5):615-33. PubMed ID: 17444847
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatitis C update.
    Valenti WM
    AIDS Read; 2007 Jan; 17(1):19-22. PubMed ID: 17274143
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pharmacological interactions in co-infected patients].
    Jáuregui Rueda H; Toibaro J
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S64-7; discussion S74-82. PubMed ID: 16862866
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hepatic transplantation in HIV-HCV co-infected patients].
    Gadano A; Aziz H; Macias S; Villamil F
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S70-3; discussion S74-82. PubMed ID: 16862868
    [No Abstract]   [Full Text] [Related]  

  • 27. Focus on hepatitis. Glimpses of hope on a distant horizon.
    Raymond D
    IAPAC Mon; 2004 Aug; 10(8):300-1. PubMed ID: 15719462
    [No Abstract]   [Full Text] [Related]  

  • 28. Recent research in HIV infection, part 2.
    Boyle BA
    AIDS Read; 2002 Dec; 12(12):524-6, 539. PubMed ID: 12518718
    [No Abstract]   [Full Text] [Related]  

  • 29. Report from the 14th Retrovirus Conference. New data on HIV and viral hepatitis coinfection.
    Albrecht H
    AIDS Clin Care; 2007 May; 19(5):41. PubMed ID: 18398990
    [No Abstract]   [Full Text] [Related]  

  • 30. Human immunodeficiency virus and the liver: lessons learned and still to be learned.
    Dieterich DT
    Semin Liver Dis; 2003 May; 23(2):107-14. PubMed ID: 12800064
    [No Abstract]   [Full Text] [Related]  

  • 31. HIV/HCV coinfection exacerbates ESLD risk.
    Highleyman L
    IAPAC Mon; 2006 Sep; 12(9):329. PubMed ID: 17378068
    [No Abstract]   [Full Text] [Related]  

  • 32. Studying new drugs for HCV. Excerpts from the FDA hearing.
    Huff B
    GMHC Treat Issues; 2006; 20(8-12):11-4. PubMed ID: 17569164
    [No Abstract]   [Full Text] [Related]  

  • 33. Current challenges in hepatitis C.
    Swan T
    Res Initiat Treat Action; 2004; 10(2):17-20. PubMed ID: 15828096
    [No Abstract]   [Full Text] [Related]  

  • 34. The challenge of hepatitis C and HIV co-infection.
    Carriero DC; Lucas J; Freemantle H; Dieterich DT
    Body Posit; 2005; 18(1):8-12, 15-7. PubMed ID: 16193566
    [No Abstract]   [Full Text] [Related]  

  • 35. Personal perspective. Living with a multiple diagnosis. An interview with Body Positive board member Patricia Shelton.
    Shelton P
    Body Posit; 2006; 19(1):31-3. PubMed ID: 16718873
    [No Abstract]   [Full Text] [Related]  

  • 36. Viral arthritis.
    Calabrese LH; Naides SJ
    Infect Dis Clin North Am; 2005 Dec; 19(4):963-80, x. PubMed ID: 16297742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tuberculosis complicating hepatitis C treatment in HIV-infected patients.
    Pérez-Elías MJ; García-San Miguel L; González García J; Montes Ramírez ML; Muriel A; Machín-Lázaro JM; Martínez-Baltanás A; Zamora F; Moreno A; Martín-Dávila P; Quereda C; Gómez-Mampaso E; Moreno S
    Clin Infect Dis; 2009 Apr; 48(8):e82-5. PubMed ID: 19275500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Management of adverse effects of hepatitis C treatment].
    González Ballerga E; Fernández N; Losso M
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S61-4; discussion S74-82. PubMed ID: 16862865
    [No Abstract]   [Full Text] [Related]  

  • 39. Co-infections. Fighting fatigue and depression in HCV/HIV co-infection.
    TreatmentUpdate; 2006; 18(1):2-3. PubMed ID: 17228457
    [No Abstract]   [Full Text] [Related]  

  • 40. Antiviral therapy: quo vadis?
    De Clercq E
    Future Med Chem; 2010 Jul; 2(7):1049-53. PubMed ID: 21426154
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.